Cargando…
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
Neutropenia and febrile neutropenia are two major complications of chemotherapy. Dose reductions, delays in treatment administration, and the use of granulocyte colony-stimulating factors are equally recommended options to preserve absolute neutrophil count in case of chemotherapy regimens bringing...
Autores principales: | Ghidini, Michele, Hahne, Jens Claus, Trevisani, Francesco, Panni, Stefano, Ratti, Margherita, Toppo, Laura, Tomasello, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928625/ https://www.ncbi.nlm.nih.gov/pubmed/27445479 http://dx.doi.org/10.2147/TCRM.S80732 |
Ejemplares similares
-
Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data
por: Ratti, Margherita, et al.
Publicado: (2019) -
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study
por: Tomasello, Gianluca, et al.
Publicado: (2017) -
Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment
por: Ratti, Margherita, et al.
Publicado: (2023) -
Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2019) -
Biliary tract cancer: current challenges and future prospects
por: Ghidini, Michele, et al.
Publicado: (2018)